GZMO Message Board - Msg: 12234173

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GZMO

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: biowa who wrote (180)	12/9/1999 10:09:00 AM
From: scaram(o)uche	Read Replies (2) of 438

Biowa: I've never assumed that "path calling" or "pathogenesis calling" would lead to too many transcript-related patents. I just assumed that it would lead to screening patents and later to composition of matter stuff. Dear Mr. Market: This is really great data that will lead to products (both therapeutic and diagnostic) much faster than silly old genomics. It's further down the pathway and relates the genes to actual disease states. It also suggests interrelations (sorry Mr. Market, I'll try to use simpler words) between the various transcripts that can't be derived from simple sequence. It also is a nice validation of the SAGE technology. Over here! Over here! Get your GZMO over here (but not from me) <g> biowa Mr. Market is a registered trademark of DAK Saw a spot on TV this week..... he's using a keyboard this year instead of Reindeer. Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next